We will be closed on Saturday July 13 due to facilities work.
Today's Hours: 12:00pm - 6:00pm

Search

Filter Applied Clear All

Did You Mean:

Search Results

  • Book
    Yasuhiko Tomino., editor
    Contents:
    Part I. Pathogenesis
    Chapter 1. Is IgA nephropathy the same disease/a homogenous disease?
    Chapter 2. Genetic variations of IgA nephropathy
    Chapter 3. Is IgA nephropathy a familial or sporadic disease?
    Chapter 4. Heterogeneity of GdIgA1
    Chapter 5. Differences of histological classification between the Japanese guideline and the Oxford classification
    Chapter 6. Podocyte injury and the role of megalin
    Chapter 7. Complement activation
    Part II. Treatment
    Chapter 8. How different are the current understandings of treatments for IgA nephropathy?
    Chapter 9. Differences in etiology and treatment in China
    Chapter 10. Differences in etiology and treatment in Korea
    Chapter 11. Differences in etiology and treatment in Japan
    Chapter 12. The VALIGA study: Differences in treatment approaches within the EU
    Chapter 13. Differences in etiology and treatment in Scandinavian countries
    Chapter14 The Implication of the KDIGO Clinical Practice Guidelines on management of IgA Nephropathy
    Chapter15 Japanese Clinical Practice Guidelines for IgA Nephropathy: Difference from KDIGO Guidelines
    Chapter16 Limitations of RAS blockade in IgA nephropathy
    Chapter17 What is the goal for proteinuria in IgA nephropathy?
    Chapter 18. Rationale of tonsillectomy and steroid pulse therapy (TSP): Is it race dependent?
    Chapter 19. Is tonsillectomy a possible treatment for IgA nephropathy from RCT?
    Chapter 20. Is tonsillectomy a possible treatment for IgA nephrology from a retrospective analysis?.
    Digital Access Springer 2016